• Mashup Score: 6

    Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that causes peripheral hyperinsulinaemia, insulin profiles that do not match basal and mealtime insulin needs, defensive snacking to avoid hypoglycaemia, or a combination of these, are…

    Tweet Tweets with this article
    • RT @TheLancetEndo: #Obesity in people living with type 1 #diabetes https://t.co/Edl98gPn5n #T1D #T1Diabetes https://t.co/55h5nLDqdq

  • Mashup Score: 1

    Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that causes peripheral hyperinsulinaemia, insulin profiles that do not match basal and mealtime insulin needs, defensive snacking to avoid hypoglycaemia, or a combination of these, are…

    Tweet Tweets with this article
    • #Obesity in people living with type 1 #diabetes https://t.co/Edl98gPn5n #T1D #T1Diabetes https://t.co/55h5nLDqdq

  • Mashup Score: 2

    Commercial automated insulin delivery therapy can improve glucose outcomes by increasing glucose time-in-range (3·9–10·0 mmol/L; 70–180 mg/dL) and reducing hypoglycaemia (<3·9 mmol/L; <70 mg/dL) in people with type 1 diabetes. Commercial closed-loop systems have shown modest improvement in percentage time-in-range, with an increase of 5 percentage points for MiniMed 670G1 and of 10 percentage...

    Tweet Tweets with this article
    • Opportunities and challenges in closed-loop systems in type 1 #diabetes https://t.co/VFZ75L4Hhs #T1D #T1Diabetes